Bruno Vergès

Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study

Bruno Vergès, Françoise Boureille, Pierre Goudet et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 477 citations · Full text

Medicine, Endocrinology, Endocrine Genetics +12

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

Matthew Capehorn, Andrei‐Mircea Catarig, Julie Kjærulff Furberg et al. · Diabetes & Metabolism · 2019 · 407 citations

Medicine, Pharmacology, Pharmacotherapy +16

European Association for the Study of the Liver (<scp>EASL</scp>), European Association for the Study of Diabetes (<scp>EASD</scp>) and European Association for the Study of Obesity (<scp>EASO</scp>) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes

Anne-Laure Sberna, Benjamin Bouillet, Alexia Rouland et al. · Diabetic Medicine · 2017 · 319 citations

Medicine, Endocrinology, Internal Medicine +17

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10